Oncology Associated Symptoms & Individualized Strategies
- Status
- WITHDRAWN
- Phase
- NA
Clinical Trials Related to Advanced Cancer
Related studies linked through entity extraction aliases.
Study of Amblyomin-X in Advanced Solid Tumor
- Status
- SUSPENDED
- Phase
- PHASE1
First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of AGEN2034 in Advanced Tumors and Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Quality of Life Intervention for Patients Receiving Radiation Therapy for Advanced Cancer Treatment and Their Caregivers
- Status
- COMPLETED
- Phase
- NA
Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy
- Status
- COMPLETED
- Phase
- N/A
Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers
- Status
- COMPLETED
- Phase
- NA
PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
- Status
- COMPLETED
- Phase
- PHASE1
Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC
- Status
- UNKNOWN
- Phase
- PHASE3
Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1